This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With deep and liquid capital markets offering unique access to the Mainland China investor market, many international businesses are considering pursuing their IPOs in Hong Kong. By: Skadden, Arps, Slate, Meagher & Flom LLP
Wilson Sonsini's 2024 Technology and Life Sciences IPO Report provides in-depth analysis on 33 initial public offerings (IPOs) completed by U.S.-based based technology and life sciences companies in 2024 with deal values exceeding $75 million. By: Wilson Sonsini Goodrich & Rosati
1] The Final Rules are intended to provide enhanced protections for investors in the initial public offerings (IPOs) of SPACs and the subsequent business combination transactions of SPACs with private operating companies (“de-SPAC transactions”). By expanding the disclosure requirements for SPAC IPOs (on. By: Robinson & Cole LLP
Think your customers will pay more for data visualizations in your application? Five years ago they may have. But today, dashboards and visualizations have become table stakes. Discover which features will differentiate your application and maximize the ROI of your embedded analytics. Brought to you by Logi Analytics.
The outlook for life sciences IPOs is showing renewed optimism heading into 2025, with market conditions becoming more constructive and regulatory environments potentially more favorable. By: Fenwick & West LLP
Sluggish M&A and IPO markets have put the brakes on private equity exit activity across Europe, but as pressure builds to clear the backlog of unsold portfolio companies, firms are taking innovative approaches to selling businesses - Europes private equity firms have a large backlog of unsold portfolio companies sitting on their books, and the (..)
capital markets’ resilience and ability to adapt, IPOs, debt markets and mergers and acquisitions (and related financings) have shown substantial increases over 2023. As a testament to the U.S.
Michael Bloch, Partner at A&O, explains, "IPOs are incredibly complex, but we are exploring ways to make them less painful for everyone involved through the adoption of legal tech.". This tech-driven approach is not just an option; it's a necessity. By: Allen & Overy LLP
As they go through their initial public offering (IPO) and the subsequent merger & acquisition (M&A) process, special purpose acquisition companies (SPACs) face many regulatory, legal, and business hurdles. Obtaining the appropriate amount and type of insurance for each stage of their life cycle is one of them.
This Summary does not contain all of the information that you will need to successfully complete your global IPO. You really should read this entire guide as well as the other Latham & Watkins publications referred to in this guide if you want to get the full picture.
14) says that there’s been an uptick in these deals and that, for some companies, they are an attractive alternative to an IPO: The trend of declining public company valuations (including a […] Despite a bit of a checkered reputation, non-SPAC reverse mergers are still a thing, and this excerpt from a recent WilmerHale memo (p.
As they go through their initial public offering (IPO) and the subsequent merger & acquisition (M&A) process, special purpose acquisition companies (SPACs) face many regulatory, legal, and business hurdles. Obtaining the appropriate amount and type of insurance for each stage of their life cycle is one of them.
By Dom Walbanke on Growth Business - Your gateway to entrepreneurial success Fintech Thought Machine has said it is in the early stages of a London IPO – a move which it is hoped could spark life into the listings market. According to Pitchbook, there is now an estimated backlog of almost 80 IPO candidates in the US.
The SEC announced that its Division of Corporation Finance is further facilitating capital formation by enhancing the accommodations available to companies for nonpublic review of draft registration statements. By: Stinson - Corporate & Securities Law Blog
The new rules affect both initial public offerings (“IPOs”) for SPACs and so-called “de-SPAC” transactions involving target companies who enter into a business combination with SPACs. Securities and Exchange Commission (the “SEC”) adopted new final rules relating to special purpose acquisition companies (“SPACs”).
With a new year just around the corner and the economy bracing for the Presidential election, those looking to IPO by Q4 2024 must prepare now. The post Failure to plan for an IPO is planning to fail appeared first on PE Hub.
SAN DIEGO COUNTY – The number of venture capital dollars flowing to Greater San Diego technology companies is becoming less frequent in 2024, a trend mirroring national investment activity that appears to favor bigger bets at the expense of more frequent ones.
Will Cava Going Public Set the Table for Other IPOs? By David Braun, Founder and CEO, Capstone Strategic When Washington DC based restaurant chain Cava became a publicly traded company recently, it bucked a trend that has lasted nearly two years, a notable absence of American IPOs.
In the second week of January, Goodwin and KPMG convened innovators, practitioners, regulators, and others for our annual symposium on the future of life sciences and healthcare. This marked the fifth year that Goodwin co-hosted the symposium, which takes place during the annual J.P. Morgan Healthcare Conference in San Francisco. By: Goodwin
Instacart's IPO filing delivered Wall Street some surprising insight into the grocery delivery business and what it means for competitors Uber and DoorDash.
Investors are hopeful that Fed rate cuts anticipated later this year will mean an uptick in traditional IPOs, and eventually pave the way for a recovery in the market.
Markets are at new highs, interest rates have been trending lower, IPO filings have been modestly active, and there is hope the calendar is going to pick up.
The post EQT-backed Kodiak debuts IPO appeared first on PE Hub. The stock began trading June 29, 2023 on the New York Stock Exchange under the ticker symbol "KGS."
Common Mistakes with IPO: The most common mistake an investors make that can be a trap and hinder your financial success is following the herd mentality
Equity and debt cheques from financial sponsors fuel growth, with investment committee appetite across the full spectrum from Seed through to late stage / pre-IPO. The payments sector bucks the trend on IPOs. Current market: M&A activity levels retain a monumental high. By: White & Case LLP
Syngenta ditches multi-billion dollar China IPO bid BEIJING (Reuters) -Swiss agrichemicals and seeds group Syngenta on Friday withdrew its bid for a multi-billion dollar listing on the Shanghai Stock Exchange during a recent period of weakness in the Chinese equity market.
Explore the unique considerations for mergers and acquisitions in the AI sector, the return of IPOs, the implications of new Supreme Court decisions and other developments in this edition of Skadden’s quarterly Insights. By: Skadden, Arps, Slate, Meagher & Flom LLP
02 A new M&A playbook in the age of AI03 Cyber enforcement forecast post-SolarWinds decision04 Cyber diligence for IPOs with Kroll’s CISO05 The Download Quiz: Venture capital trends from Europe. 01 Do I need to make money to go public?02 By: Orrick, Herrington & Sutcliffe LLP
With SPAC IPOs virtually gone but SPAC mergers (aka de-SPACs) continuing at a steady pace since the beginning of the year, the questions around getting a deal done boil down to the following: How and where can companies get financing now that the PIPE (private investment in public equity) market has dried up?
The 2012 JOBS Act permitted Emerging Growth Companies to initiate the IPO process by submitting their IPO registration statements confidentially to the SEC for nonpublic review by the SEC staff.
The S&P 500 has been cracking fresh highs, but the IPO market remains sluggish in 2024. Market observers hope two new deals could help thaw things out.
The reverse merger is among one of the oldest alternatives to a conventional IPO for a private company seeking to become publicly traded and, due to a confluence of factors, has recently gained greater marketplace acceptance. In recent years, a variety of alternative paths to public ownership and trading liquidity have emerged.
Cautious deployment of M&A war chests while concerns relating to IPO and equity market trading buoyancy continue. Current market: Fewer M&A deals as Europe's FMI tectonic plates digest acquisitions of yesteryear. By: White & Case LLP
Life sciences venture capital (VC) funding and IPOs have picked up in 2024, and anticipated Federal Reserve interest rate cuts will likely further accelerate this trend. The life sciences industry is well positioned for growth in 2025, fueled by strong investor interest and technological advancements, especially in AI. By: Goodwin
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content